Thermo Fisher Scientific Inc. (NYSE:TMO) to Issue $0.43 Quarterly Dividend

Thermo Fisher Scientific Inc. (NYSE:TMO) announced a quarterly dividend on Thursday, November 6th. Investors of record on Monday, December 15th will be given a dividend of 0.43 per share by the medical research company on Thursday, January 15th. This represents a c) dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Monday, December 15th.

Thermo Fisher Scientific has increased its dividend by an average of 0.2%annually over the last three years and has increased its dividend every year for the last 8 years. Thermo Fisher Scientific has a payout ratio of 7.0% indicating that its dividend is sufficiently covered by earnings. Analysts expect Thermo Fisher Scientific to earn $25.56 per share next year, which means the company should continue to be able to cover its $1.72 annual dividend with an expected future payout ratio of 6.7%.

Thermo Fisher Scientific Stock Up 1.0%

NYSE:TMO traded up $5.63 during trading hours on Friday, hitting $571.61. 1,230,479 shares of the company traded hands, compared to its average volume of 2,374,605. Thermo Fisher Scientific has a one year low of $385.46 and a one year high of $610.97. The company has a quick ratio of 1.11, a current ratio of 1.50 and a debt-to-equity ratio of 0.62. The company has a market cap of $214.76 billion, a PE ratio of 33.11, a PEG ratio of 3.27 and a beta of 0.82. The firm’s 50-day simple moving average is $516.99 and its 200-day simple moving average is $461.35.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, October 22nd. The medical research company reported $5.79 earnings per share for the quarter, beating analysts’ consensus estimates of $5.50 by $0.29. Thermo Fisher Scientific had a net margin of 15.02% and a return on equity of 16.97%. The company had revenue of $11.12 billion for the quarter, compared to analyst estimates of $10.90 billion. During the same period last year, the firm earned $5.28 earnings per share. The firm’s revenue was up 4.9% on a year-over-year basis. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS. Equities analysts predict that Thermo Fisher Scientific will post 23.28 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Barclays boosted their target price on Thermo Fisher Scientific from $585.00 to $625.00 and gave the stock an “overweight” rating in a research note on Thursday, October 23rd. William Blair started coverage on Thermo Fisher Scientific in a research note on Monday, August 18th. They issued an “outperform” rating for the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, October 14th. Redburn Partners set a $580.00 price target on shares of Thermo Fisher Scientific in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Thermo Fisher Scientific from $600.00 to $650.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Nineteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $601.65.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.